EdgeScore

JUNS · Nasdaq

JUPITER NEUROSCIENCES, INC.: financial statements

Insufficient data · see the checkFigures in USD, fiscal years

Revenue and net income

Revenue 2024: $0Net income 2024: -$2.4M2024Revenue 2025: $21.8KNet income 2025: -$8.6M2025
RevenueNet income

Operating and free cash flow

Operating cash flow 2024: -$3.9MFree cash flow 2024: -$3.9M2024Operating cash flow 2025: -$5.4MFree cash flow 2025: -$5.4M2025
Operating cash flowFree cash flow

Margins

Gross 2025: 80.6%Operating 2025: -40873.2%Net 2025: -39662.8%20242025
GrossOperatingNet

Returns

ROE 2024: -58.5%ROIC 2024: -606.7%ROA 2024: -39.3%ROA 2025: -155.4%20242025
ROEROICROA

Income statement

USD20242025Last year
Revenue$0$21.8K
Gross profit—$17.6K
Selling, general & admin—$6.8M
Operating income-$3.1M-$8.9M-188%
EBITDA-$3.1M-$8.9M-188%
Interest expense$248K$66.0K-73%
Net income-$2.4M-$8.6M-254%

Cash flow

USD20242025Last year
Operating cash flow-$3.9M-$5.4M-38%
Free cash flow-$3.9M-$5.4M-38%

Balance sheet

USD20242025Last year
Cash$3.8M$3.8M+1%
Inventory—$160K
Current assets$4.7M$4.8M+4%
Total assets$6.2M$5.6M-10%
Current liabilities$2.0M$7.4M+268%
Total liabilities$2.0M$7.4M+264%
Shareholders' equity$4.2M-$1.8M-144%
Net debt-$3.8M-$3.8M-1%

Ratios

20242025Last year
Gross margin—80.6%
Operating margin—-40873.2%
Net margin—-39662.8%
SG&A as share of revenue—31380.6%
Return on equity-58.5%—
Return on assets-39.3%-155.4%
Return on invested capital-606.7%—
Interest coverage-12.4x-134.9x
Current ratio2.310.65
Quick ratio2.310.63

Data source: SEC EDGAR, company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.

For information and education only. Not investment advice. Data may contain errors.